Antibiotic Resistance Pattern Among Isolated Bacteria from Urinary Tract Infection Patients in the Intensive Care Unit
Abstract
Background: Urinary tract infection (UTI) is one of the most important health care issues with a major role in occurrence of nosocomial infections. Rise in antibiotic resistance rate by UTIs not only lead to morbidity and mortality, but also impose a remarkable financial burden on health care infrastructure. This study was undertaken to evaluate the prevalence of UTIs and identify common microorganisms responsible for infection and their antibiotic resistance profile in our Intensive Care Unit (ICU).
Methods: In this perspective cross-sectional study, data from patients admitted to the ICU of two main referral hospitals in Yasouj, Southern-west Iran from 2015- 2016 was collected. Patients were selected in a subsequent manner and were asked to provide a midstream urine sample. Positive cultures were subsequently placed in differential culture medium for the diagnosis of the causative pathogen, while also evaluating with Muller Hinton Agar culture for antibiogram through disc diffusion method, to evaluate the pathogens sensitivity and resistance towards the tested antibiotics.
Results: Based on bacterial culture results among a total of 112 obtained urine samples, 100 (89.2%) were negative while 12 (10.8%) were positive, in which the majority were gram-negative (6.25%) and the most frequent pathogen was Escherichia coli (5.3%). All cases of UTI in our population were fully resistant to cephalexin, ampicillin, and amoxicillin. Also, all gram-negative cultures were sensitive to amikacin. There was also no significant association between the antibiogram results with age, gender, and gram results.
Conclusion: we report actual data on the resistance patterns of uro-pathogens in a public hospital in Iran. Escherichia coli showed a high prevalence among all UTIs with lower resistance rates to the antibiotics. Resistance to nalidixic acid and trimethoprim-sulfamethoxazole were significantly lower than other oral antibiotics, making both a suitable and cheap alternative for the empirical treatment.
2. Wang R, LaSala C. Role of antibiotic resistance in urinary tract infection management: a cost-effectiveness analysis. Am J Obstet Gynecol 2021; 225(5):550.e1.
3. Najar MS, Saldanha CL, Banday KA. Approach to urinary tract infections. Indian J Nephrol 2009; 19(4):129-39.
4. Liu Y, Xiao D, Shi XH. Urinary tract infection control in intensive care patients. Medicine (Baltimore) 2018; 97(38):e12195.
5. Mota É C, Oliveira AC. Catheter-associated urinary tract infection: why do not we control this adverse event? Rev Esc Enferm USP 2019; 53:e03452.
6. Woldemariam HK, Geleta DA, Tulu KD, et al. Common uropathogens and their antibiotic susceptibility pattern among diabetic patients. BMC Infect Dis 2019; 19(1):43.
7. Nouri F, Karami P, Zarei O, et al. Prevalence of common nosocomial infections and evaluation of antibiotic resistance patterns in patients with secondary infections in Hamadan, Iran. Infect Drug Resist 2020; 13:2365-74.
8. Adugna B, Sharew B, Jemal M. Bacterial profile, antimicrobial susceptibility pattern, and associated factors of community- and hospital-acquired urinary tract infection at Dessie Referral Hospital, Dessie, Northeast Ethiopia. Int J Microbiol 2021; 2021:5553356.
9. Lee DS, Lee SJ, Choe HS. Community-acquired urinary tract infection by Escherichia coli in the Era of antibiotic resistance. Biomed Res Int 2018; 2018:7656752.
10. Ahmadishooli A, Davoodian P, Shoja S, et al. frequency and antimicrobial susceptibility patterns of diabetic foot infection of patients from Bandar Abbas District, Southern Iran. Journal of pathogens 2020;2020. 1057167.
11. Mihankhah A, Khoshbakht R, Raeisi M, et al. Prevalence and antibiotic resistance pattern of bacteria isolated from urinary tract infections in Northern Iran. J Res Med Sci 2017; 22:108.
12. Ho HJ, Tan MX, Chen MI, et al. Interaction between antibiotic resistance, resistance genes, and treatment response for urinary tract infections in primary care. J Clin Microbiol 2019; 57(9):e00143-19.
13. Bonnet V, Dupont H, Glorion S, et al. Influence of bacterial resistance on mortality in intensive care units: a registry study from 2000 to 2013 (IICU Study). J Hosp Infect 2019; 102(3):317-24.
14. Rezai MS, Bagheri-Nesami M, Nikkhah A. Catheter-related urinary nosocomial infections in intensive care units: An epidemiologic study in North of Iran. Caspian J Intern Med 2017; 8(2):76-82.
15. Bagshaw SM, Laupland KB. Epidemiology of intensive care unit-acquired urinary tract infections. Curr Opin Infect Dis 2006; 19(1):67-71.
16. Leone M, Albanèse J, Garnier F, et al. Risk factors of nosocomial catheter-associated urinary tract infection in a polyvalent intensive care unit. Intensive Care Med 2003; 29(6):929-32.
17. Laupland KB, Bagshaw SM, Gregson DB, et al. Intensive care unit-acquired urinary tract infections in a regional critical care system. Crit Care 2005; 9(2):R60-5.
18. Córdoba G, Holm A, Hansen F, et al. Prevalence of antimicrobial resistant Escherichia coli from patients with suspected urinary tract infection in primary care, Denmark. BMC Infect Dis 2017; 17(1):670.
19. Alanazi MQ, Alqahtani FY, Aleanizy FS. An evaluation of E. coli in urinary tract infection in emergency department at KAMC in Riyadh, Saudi Arabia: retrospective study. Ann Clin Microbiol Antimicrob 2018; 17(1):3.
20. Mohamed MA, Abdifetah O, Hussein FA, et al. Antibiotic resistance pattern of Escherichia coli isolates from outpatients with urinary tract infections in Somalia. J Infect Dev Ctries 2020; 14(3):284-9.
21. Wagenlehner FME, Bjerklund Johansen TE, Cai T, et al. Epidemiology, definition and treatment of complicated urinary tract infections. Nat Rev Urol 2020; 17(10):586-600.
22. Puri J, Mishra B, Mal A, et al. Catheter associated urinary tract infections in neurology and neurosurgical units. J Infect 2002; 44(3):171-5.
23. Marques LP, Flores JT, Barros Junior Ode O, et al. Epidemiological and clinical aspects of urinary tract infection in community-dwelling elderly women. Braz J Infect Dis 2012; 16(5):436-41.
24. Choe HS, Lee SJ, Cho YH, et al. Aspects of urinary tract infections and antimicrobial resistance in hospitalized urology patients in Asia: 10-Year results of the Global Prevalence Study of Infections in Urology (GPIU). J Infect Chemother.2018; 24(4):278-83.
25. Mortazavi-Tabatabaei SAR, Ghaderkhani J, Nazari A, et al. Pattern of Antibacterial Resistance in Urinary Tract Infections: A Systematic Review and Meta-analysis. Int J Prev Med 2019; 10:169.
26. Minardi D, d'Anzeo G, Cantoro D, et al. Urinary tract infections in women: etiology and treatment options. Int J Gen Med 2011; 4:333-43.
27. Goldstein FW. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group. Eur J Clin Microbiol Infect Dis 2000; 19(2):112-7.
28. Gray BM, Stevens DL. Streptococcal Infections: Bacterial Infections of Humans. 2009 May 29:743-82.
29. Eslami G, Salehifar E, Behbudi M, et al. Rational use of amikacin in Buali-Sina Hospital in Sari 2011. J Mazandaran Univ Med Sci 2013; 23(100):2-9.
30. Bean DC, Krahe D, Wareham DW. Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005-2006. Ann Clin Microbiol Antimicrob 2008; 7:13.
31. Peterson J, Kaul S, Khashab M, et al. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006. Clin Ther 2007; 29(10):2215-21.
32. Mostafavi SN, Rostami S, Nejad YR, et al. Antimicrobial resistance in hospitalized patients with community acquired urinary tract infection in Isfahan, Iran. Archives of Iranian Medicine 2021; 24(3):187-92.
33. Adukauskiene D, Kinderyte A, Tarasevicius R, et al. [Etiology, risk factors, and outcome of urinary tract infection]. Medicina (Kaunas). 2006; 42(10):805-9.
34. Agarwal R, Gupta D, Ray P, et al. Epidemiology, risk factors and outcome of nosocomial infections in a respiratory intensive care unit in North India. J Infect. 2006; 53(2):98-105.
35. Eckenrode S, Bakullari A, Metersky ML, et al. The association between age, sex, and hospital-acquired infection rates: results from the 2009-2011 National Medicare Patient Safety Monitoring System. Infect Control Hosp Epidemiol 2014; 35 Suppl 3:S3-9.
36. Li F, Song M, Xu L, et al. Risk factors for catheter-associated urinary tract infection among hospitalized patients: A systematic review and meta-analysis of observational studies. J Adv Nurs 2019; 75(3):517-27.
37. Perrin K, Vats A, Qureshi A, et al. Catheter-associated urinary tract infection (CAUTI) in the NeuroICU: identification of risk factors and time-to-cauti using a case-control design. Neurocrit Care 2021; 34(1):271-8.
38. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharmacy Therapeutics 2015; 40(4):277-83.
Files | ||
Issue | Vol 11 No 5-6 (2023) | |
Section | Original Articles | |
DOI | https://doi.org/10.18502/jmb.v11i5-6.14360 | |
Keywords | ||
Anti-Bacterial Agents Escherichia coli Intensive Care Unit Urinary Tract Infection Resistance pattern . |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |